Posted by Michael Wonder on 01 Jul 2020
PBS listings to benefit Australians with type 2 diabetes and small cell lung cancer, emergency dispensing measures of PBS medicines extended
30 June 2020 - The importance of the Pharmaceutical Benefits Scheme has been underlined with new and amended medicines listings on the PBS, and an extension to emergency dispensing measures to support patients during the COVID-19 pandemic.
From 1 July the medicine Ozempic (semaglutide) will be listed on the PBS as a new treatment option for type 2 diabetes mellitus.
From 1 July, the listing of Tecentriq (atezolizumab) will be expanded and improved to include a new form and treatment regimen to assist patients with small cell lung cancer.
